Daniel Simon

Daniel Simon

Company: Revolution Medicines

Job title: Chief Business Officer

Seminars:

Patient Selection & Stratification in RAS Targeted Therapeutics Clinical Trials 9:00 am

Patient characteristics and stratification factors are critical features which can influence the outcome of clinical trials. This is a key consideration which must be taken into account when we design, develop and conduct clinical trials for anti-RAS therapeutics. However, understanding the patient characteristics, truly capturing how to implement this into clinical trials and what this…Read more

day: Pre-Conference Day Track B

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.